Lytix Biopharma AS Net Asset Quality Index
Lytix Biopharma AS net asset quality index. Lytix Biopharma AS (LYTIX) has a Net Asset Quality Index of 75.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Nkr81.52 Million minus total liabilities of Nkr19.77 Million yields net assets of Nkr61.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore Lytix Biopharma AS (LYTIX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Lytix Biopharma AS (2017–2025)
Net asset quality index of Lytix Biopharma AS from 2017 to 2025. This chart shows how Lytix Biopharma AS's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 75.7%, representing net assets of Nkr61.75 Million against total assets of Nkr81.52 Million NOK. See net assets of Lytix Biopharma AS for net asset value and shareholders' equity analysis.
Lytix Biopharma AS Net Asset Quality Index by Year (2017–2025)
Lytix Biopharma AS net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Lytix Biopharma AS from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lytix Biopharma AS market capitalisation.
| Year | Quality Index | Net Assets (NOK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.7% | Nkr61.75 Million | Nkr81.52 Million | Nkr19.77 Million | ▲ +2.1 pp |
| 2024 | 73.6% | Nkr107.89 Million | Nkr146.53 Million | Nkr38.64 Million | ▼ -6.7 pp |
| 2023 | 80.3% | Nkr51.32 Million | Nkr63.87 Million | Nkr12.55 Million | ▼ -8.5 pp |
| 2022 | 88.9% | Nkr135.13 Million | Nkr152.02 Million | Nkr16.89 Million | ▼ -4.5 pp |
| 2021 | 93.4% | Nkr189.62 Million | Nkr202.96 Million | Nkr13.34 Million | ▲ +32.5 pp |
| 2020 | 61.0% | Nkr19.89 Million | Nkr32.62 Million | Nkr12.73 Million | ▼ -16.9 pp |
| 2019 | 77.9% | Nkr13.58 Million | Nkr17.43 Million | Nkr3.85 Million | ▲ +8.2 pp |
| 2018 | 69.7% | Nkr41.05 Million | Nkr58.90 Million | Nkr17.85 Million | ▲ +44.7 pp |
| 2017 | 25.0% | Nkr11.79 Million | Nkr47.09 Million | Nkr35.30 Million | — |